Related Experiment Videos
[Criteria for selecting antibacterial drugs for use in newborn infants]
A Viganò1, A Dalla Villa, P Tommasi
1Clinica Pediatrica IV, Università di Milano, Italia.
Insights
Early and targeted antibacterial therapy is crucial for newborns with sepsis. Understanding drug pharmacokinetics and pathogen resistance guides effective treatment, improving outcomes.
Area of Science:
- Clinical Pharmacology
- Neonatal Medicine
- Infectious Diseases
Context:
- Advancements in clinical pharmacology have improved understanding of antibacterial drug disposition in newborns.
- Challenges remain in early and targeted sepsis therapy for neonates.
- Accurate diagnosis of neonatal sepsis is difficult due to subtle and nonspecific clinical signs.
Purpose:
- To highlight the importance of early and precise antibacterial therapy in neonatal sepsis.
- To emphasize the need for interpreting bacterial epidemiology and drug sensitivity data.
- To discuss the role of rapid diagnostic tests in guiding therapy adjustments.
Summary:
- Effective antibacterial therapy for neonatal sepsis requires understanding drug absorption, distribution, and elimination in newborns.
- Distinguishing between early and late sepsis is vital for identifying causative agents and guiding empirical treatment.
- Hematologic and rapid etiologic diagnostic tests aid in early sepsis diagnosis and modification of initial antibacterial strategies.
Impact:
- Improved diagnostic accuracy for neonatal sepsis.
- Optimized antibacterial drug selection and dosing in newborns.
- Reduced incidence of "non-diagnosis" and overuse of antibiotics in neonatal sepsis cases.
Abstract:
During the last years many advancements have been made in the field of clinical pharmacology. Nowadays we have a better understanding of the factors influencing absorption, distribution and elimination of antibacterial drugs in the newborn. However many problems have not been faced yet; of primary importance are earliness and aiming of therapy. Much has been written about the use of hematologic screening tests for an early diagnosis of sepsis and the use of tests for a rapid etiologic diagnosis. This is probably the result not only of the commonly encountered difficulty in making a clinical diagnosis of sepsis (based on clinical findings that are often insidious and aspecific) but also of the implications concerning either a "non-diagnosis" or a large use of antibacterial drugs. The choice of an appropriate antibacterial therapy in the newborn with sepsis implies a careful interpretation of the data concerning: 1) bacterial epidemiology and 2) sensitivity towards drugs of the bacterial most commonly identified in sepsis. For that purpose, it is important to distinguish between early and late sepsis and between the etiological agents more frequently responsible for the first and those for the later. Moreover it is important to consider the role of rapid tests in the etiological diagnosis, as a guide to the modification of the initial empirical therapy.